Top

International Journal of Clinical Oncology

Published in:

01-06-2008 | Erratum

No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan

Authors: Toshiaki Saeki, Muneo Sano, Yoshifumi Komoike, Hiroshi Sonoo, Hideo Honjyo, Kazunori Ochiai, Tadashi Kobayashi, Kenjiro Aogi, Nobuaki Sato, Seiji Sawai, Yasuo Miyoshi, Masahiro Takeuchi, Shigemitsu Takashima

Published in: International Journal of Clinical Oncology | Issue 3/2008

Title: No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan
Authors: Toshiaki Saeki
Muneo Sano
Yoshifumi Komoike
Hiroshi Sonoo
Hideo Honjyo
Kazunori Ochiai
Tadashi Kobayashi
Kenjiro Aogi
Nobuaki Sato
Seiji Sawai
Yasuo Miyoshi
Masahiro Takeuchi
Shigemitsu Takashima
Publication date: 01-06-2008
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 3/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-008-0794-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2008

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

Placental-site trophoblastic tumor with PET scan-detected surgically treated lung metastasis

Surgery and adjuvant chemotherapy

Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1–10.0 ng/ml as a criterion

Endometrioid adenocarcinoma arising in adenomyosis: elucidation by periodic magnetic resonance imaging evaluations

Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer